• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

固体乙酰唑胺复合物的特性、溶解和体内评价。

Characterization, dissolution and in vivo evaluation of solid acetazolamide complexes.

机构信息

Departamento de Farmacia, UNITEFA, CONICET, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Córdoba, X5000HUA, Argentina.

出版信息

Carbohydr Polym. 2013 Oct 15;98(1):380-90. doi: 10.1016/j.carbpol.2013.06.012. Epub 2013 Jun 20.

DOI:10.1016/j.carbpol.2013.06.012
PMID:23987358
Abstract

The effects of binary and ternary systems of acetazolamide (ACZ) with hydroxypropyl-β-cyclodextrin (HP-β-CD) alone or with triethanolamine (TEA) on the crystalline properties, dissolution and intraocular pressure (IOP)-lowering effect were investigated. It was found that the crystal structure of ACZ powder could be modified by the processing conditions. Freeze-drying ACZ powder affected not only the particle morphology but also its polymorphic form and the starting ACZ was converted to pure form A upon freeze-drying treatment. Results provided by DSC/TGA, XRPD, SEM and FT-IR suggested the formation of inclusion complexes between ACZ with HP-β-CD alone or with TEA, obtained by the freeze-drying method and the conversion of the drug into the amorphous state. Binary and ternary systems of ACZ obtained by freeze-drying exhibited significantly enhanced ACZ dissolution rates. The IOP-lowering effects of ACZ and its complexes with HP-β-CD alone or with TEA were studied in normotensive rabbits. Whereas the maximum IOP-lowering effect (~4 mmHg, ~33%), obtained with these binary and ternary lyophilized ACZ systems occurred at around 90 min, the ternary system exhibited a longer maximum IOP-lowering effect peak compared with that of the binary system. These results are in line with those obtained from the dissolution studies, where the ternary system exhibited longer dissolution times compared to the lyophilized binary one. Results obtained from the dissolution studies, also showed that freeze-drying the native crystalline form of ACZ significantly increased the dissolution rate of ACZ, thus improving the IOP-lowering effect of this drug.

摘要

研究了乙酰唑胺(ACZ)与羟丙基-β-环糊精(HP-β-CD)的二元和三元体系以及与三乙醇胺(TEA)的二元和三元体系对晶体性质、溶解和眼压(IOP)降低作用的影响。结果发现,ACZ 粉末的晶体结构可以通过加工条件进行修饰。冻干 ACZ 粉末不仅影响颗粒形态,还影响其多晶型形式,起始 ACZ 在冻干处理后转化为纯 A 型。DSC/TGA、XRPD、SEM 和 FT-IR 的结果表明,ACZ 与 HP-β-CD 单独或与 TEA 形成包合复合物,通过冻干法获得,并将药物转化为无定形态。冻干得到的 ACZ 二元和三元体系表现出明显增强的 ACZ 溶解速率。在正常眼压兔中研究了 ACZ 及其与 HP-β-CD 单独或与 TEA 形成的复合物的降眼压作用。虽然这些冻干的二元和三元 ACZ 系统的最大眼压降低作用(4mmHg,33%)发生在大约 90 分钟左右,但与二元系统相比,三元系统表现出更长的最大眼压降低作用峰。这些结果与溶解研究的结果一致,其中三元系统的溶解时间比冻干的二元系统长。溶解研究的结果还表明,冻干 ACZ 的天然晶体形式显著提高了 ACZ 的溶解速率,从而提高了该药物的降眼压作用。

相似文献

1
Characterization, dissolution and in vivo evaluation of solid acetazolamide complexes.固体乙酰唑胺复合物的特性、溶解和体内评价。
Carbohydr Polym. 2013 Oct 15;98(1):380-90. doi: 10.1016/j.carbpol.2013.06.012. Epub 2013 Jun 20.
2
Synthesis, characterization and in vitro release studies of a new acetazolamide-HP-beta-CD-TEA inclusion complex.一种新型乙酰唑胺 - HP-β - 环糊精 - 三乙胺包合物的合成、表征及体外释放研究
Eur J Med Chem. 2008 Mar;43(3):464-70. doi: 10.1016/j.ejmech.2007.03.037. Epub 2007 Apr 24.
3
An efficient ternary complex of acetazolamide with HP-ss-CD and TEA for topical ocular administration.一种用于眼部局部给药的乙酰唑胺与HP-ss-CD和TEA的高效三元复合物。
J Control Release. 2009 Aug 19;138(1):24-31. doi: 10.1016/j.jconrel.2009.04.035. Epub 2009 May 6.
4
Intestinal uptake and toxicity evaluation of acetazolamide and its multicomponent complexes with hidroxypropyl-β-cyclodextrin in rats.乙酰唑胺及其与羟丙基-β-环糊精的多组分复合物在大鼠体内的肠道吸收及毒性评价
Int J Pharm. 2015 Jan 15;478(1):258-267. doi: 10.1016/j.ijpharm.2014.11.027. Epub 2014 Nov 13.
5
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.他达拉非与天然及化学修饰的β-环糊精的包合物。I:制备及体外评价
Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4.
6
Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.卤泛群-2-羟丙基-β-环糊精二元体系的溶出特性及表征
Pharmazie. 2007 Nov;62(11):858-63.
7
The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-beta-cyclodextrin.pH值和三乙醇胺对磺胺异恶唑与羟丙基-β-环糊精络合的影响。
Eur J Pharm Sci. 2003 Nov;20(3):285-93. doi: 10.1016/s0928-0987(03)00202-1.
8
Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.奥美拉唑与天然及化学修饰β-环糊精包合物的固态表征及溶出曲线
Eur J Pharm Biopharm. 2007 Sep;67(2):531-9. doi: 10.1016/j.ejpb.2007.03.005. Epub 2007 Mar 13.
9
Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination.抗坏血酸分别与羟丙基-β-环糊精和三乙醇胺以及二者组合的相互作用研究。
J Pharm Biomed Anal. 2007 Nov 30;45(4):536-45. doi: 10.1016/j.jpba.2007.07.030. Epub 2007 Aug 6.
10
Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system.萘普生-精氨酸-羟丙基-β-环糊精三元体系的固态表征及溶解性能
Eur J Pharm Biopharm. 2005 Jan;59(1):99-106. doi: 10.1016/j.ejpb.2004.05.005.

引用本文的文献

1
Chitosan-TPP Nanogels for Ocular Delivery of Folic Acid: Release Profile, Corneal Permeation, and Mucoadhesion Assessment.用于眼部递送叶酸的壳聚糖-三聚磷酸钠纳米凝胶:释放曲线、角膜渗透及黏膜粘附性评估
Pharmaceutics. 2025 Mar 27;17(4):424. doi: 10.3390/pharmaceutics17040424.
2
Inclusion Complexes of Ethanamizuril with β- and Hydroxypropyl-β-Cyclodextrin in Aqueous Solution and in Solid State: A Comparison Study.乙胺嘧啶与β-环糊精和羟丙基-β-环糊精在水溶液和固态中的包合物:一项比较研究。
Molecules. 2024 May 7;29(10):2164. doi: 10.3390/molecules29102164.
3
Ocular administration of acetazolamide microsponges in situ gel formulations.
乙酰唑胺微海绵原位凝胶制剂的眼部给药。
Saudi Pharm J. 2018 Nov;26(7):909-920. doi: 10.1016/j.jsps.2018.01.005. Epub 2018 Sep 24.
4
Understanding absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles.理解吸收:监管方面以及应对溶解性和渗透性障碍的当代方法。
Acta Pharm Sin B. 2017 May;7(3):260-280. doi: 10.1016/j.apsb.2016.09.005. Epub 2016 Nov 2.